Chembio announced launch of DPP COVID-19 serological point-of-care test
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
-
-
Artificial Intelligence | Biotechnology | COVID-19 | Infectious Disease | Life Science History | Non-Profit Research | Pharmaceutical | Therapeutics
COVID-19 first target of new AI research consortium
On Mar. 26, 2020, the University of California, Berkeley, and University of Illinois at Urbana-Champaign were selected a…
-
Sorrento and SmartPharm Therapeutics announced research and development collaboration develop a next-generation, gene-encoded antibody vaccine for COVID-19
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science History | Non-Profit Research | Therapeutics
Acura Pharmaceuticals provides an update on the development of LTX-03
On Mar. 23, 2020, Acura Pharmaceuticals announced that Abuse Deterrent Pharma, its licensee of LTX-03 (Hydrocodone Bitartrate and…
-
Researcher proved one of Darwin’s theories of evolution 140 years after his death
On Mar. 18, 2020, Laura van Holstein and and Robert A. Foley published “Terrestrial habitats decouple the relationship…
-
Abbott received FDA Emergency Use Authorization and launched test to detect novel Coronavirus
On Mar. 18, 2020, Abbott announced that the the U.S. Food and Drug Administration had issued Emergency Use…
-
Getinge increased production capacity of ventilators with 60% to support the needs of global ICU’s
On Mar. 17, 2020, Getinge has since the outbreak of the COVID-19 pandemic seen an increased global demand…
-
Long-term analysis showed GM cotton no match for insects in India
On Mar. 13, 2020, Washington University in St. Louis announced the first long-term study of Bacillus thuringiensis (Bt)…
-
Newer anti-HIV drugs safest, most effective during pregnancy
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
-
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
-
Bayer advanced more sustainable agricultural solutions utilizing new innovative greenhouses in Marana, Arizona
On Mar. 4, 2020, Bayer announced it had opened what the firm calls its new smart, state-of-the-art, automated…
-
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
-
The FDA approved a generic version of Daraprim for the treatment of toxoplasmosis
On Feb. 28, 2020, the FDA approved an application for the first generic of Daraprim (pyrimethamine) tablets for…
-
Altimmune Completed First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
On Feb. 28, 2020, Altimmune announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology…
-
Clover and GSK announced research collaboration to evaluate Coronavirus vaccine candidate with pandemic adjuvant system
On Feb. 24, 2020, Clover Biopharmaceuticals announced a research collaboration with GSK for its protein-based coronavirus vaccine candidate…
-
Innovation Pharma submited Material Transfer Agreement to study defensin mimetic Brilacidin for Coronavirus
On Feb. 24, 2020, Innovation Pharmaannounced the Company submitted a Material Transfer Agreement (MTA) with a leading U.S.-based…
-
Innovation Pharma’s Brilacidin tested as drug and vaccine at different institutions
On Feb. 18, 2020, Innovation Pharma announced the Company was exploring its lead defensin mimetic drug candidate, Brilacidin,…
-
World experts and funders set priorities for COVID-19 research
On Feb. 12, 2020, leading health experts from around the world met at the World Health Organization’s (WHO)…
-
Chembio Diagnostics received $1.5 million UNICEF order to combat Zika
On Feb. 12, 2020, Chembio Diagnostics announced a $1.5 million purchase order from UNICEF for multiplex Zika tests…
-
UNMC researchers part of $32 million international project for drug development
On Feb. 7, 2020, two University of Nebraska Medical Center faculty members are among a group of researchers…
-
CEPI and GSK announced collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
On Feb. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed…
-
CDC released the 2020 recommended immunization schedules for children and adolescents, as well as for adults
On Feb. 3, 2020, the CDC released the 2020 recommended immunization schedules for children and adolescents, as well…
-
Mammoth Biosciences secured contract from NIH to scale high-throughput CRISPR SARS-CoV-2 diagnostic platform
On Jan. 31, 2020, Mammoth Biosciences announced the company had received a contract from the National Institutes of…
-
NIH officials discussed novel coronavirus that recently emerged in China
On Jan. 23, 2020, the new cluster of viral pneumonia cases originating in Wuhan, China, marked the third…
-
The Vanderbilt Vaccine Research Program received NIH grant to continue work as Vaccine and Treatment Evaluation
On Jan. 23, 2020, the Vanderbilt Vaccine Research Program (VVRP) received a grant from the National Institutes of…
-
Johns Hopkins engineering professor Dr Lauren Gardner created the COVID dashboard used around the world to track the novel coronavirus outbreak
On Jan. 22, 2020, Johns Hopkins engineering professor Dr. Lauren Gardner created the COVID dashboard used around the…
-
TB Alliance announced partnership with Hongqi Pharma to commercialize therapy for d Drug-resistant TB in China
On Jan. 17, 2020, the Non-profit drug developer TB Alliance granted Shenyang Hongqi Pharmaceuticals , a subsidiary of…
-
Secretary Azar declared Public Health Emergency for the U.S. for 2019 Novel Coronavirus
On Jan 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency…
-
Vanderbilt researchers discovered a new genetic disease
On Jan. 13, 2020, Vanderbilt University Medical Center researcher Ela Knapik, MD and her colleagues announced they had…
-
University of Vermont and Tufts University researchers build the first living robots
On Jan. 13, 2020, a team of scientists from the University of Vermont and Tufts University annouced they…
